ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Arzerra Given Accelerated Approval For Leukemia

October 30, 2009

In Brief: Breast Cancer Tape ready; control Program Plans for 1978 Subject Of July 15 Meeting

June 17, 1977

Cooperative Groups: Group Affiliates, Statistical Offices At Top Of NCI’s Most Needy Cases List

November 13, 1998

Three Venerable Acronyms Fade Away As Cooperative Groups Form “Alliance”

June 17, 2011

Garb’s Questions, Answers About Cancer Program

December 12, 1980

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

July 17, 1992